Kathryn E. Falberg, Director at Nuvation Bio Inc. (NUVB), bought 410,000 shares at $1.97 ($789K) on 2022-12-01, disclosed to the SEC on 2022-12-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.85 | 75,041 | $139K | 17.6% |
| 2 | $1.85 | 75,041 | $139K | 17.6% |
| 3 | $1.97 | 84,959 | $167K | 21.2% |
| 4 | $1.97 | 84,959 | $167K | 21.2% |
| 5 | $1.98 | 47,000 | $93K | 11.8% |
| 6 | $1.95 | 43,000 |
| $84K |
| 10.6% |
| Total | $1.93 avg | 410,000 | $789K | 100% |
| Filing → |
| TTD | SELL | 2024-03-12 | $16.9M | — | Filing → |
| TTD | SELL | 2021-11-23 | $32.5M | — | Filing → |
| RCUS | BUY | 2021-04-02 | $567K | — | Filing → |